"Neovascularization, Pathologic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A pathologic process consisting of the proliferation of blood vessels in abnormal tissues or in abnormal positions.
Descriptor ID |
D009389
|
MeSH Number(s) |
C23.550.589.500
|
Concept/Terms |
Neovascularization, Pathologic- Neovascularization, Pathologic
- Pathologic Neovascularization
- Neovascularization, Pathological
- Pathological Neovascularization
- Pathologic Angiogenesis
- Angiogenesis, Pathologic
- Angiogenesis, Pathological
- Pathological Angiogenesis
|
Below are MeSH descriptors whose meaning is more general than "Neovascularization, Pathologic".
Below are MeSH descriptors whose meaning is more specific than "Neovascularization, Pathologic".
This graph shows the total number of publications written about "Neovascularization, Pathologic" by people in this website by year, and whether "Neovascularization, Pathologic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2008 | 0 | 1 | 1 |
2011 | 0 | 1 | 1 |
2015 | 1 | 1 | 2 |
2016 | 0 | 1 | 1 |
2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neovascularization, Pathologic" by people in Profiles.
-
Although Abundant in Tumor Tissue, Mast Cells Have No Effect on Immunological Micro-milieu or Growth of HPV-Induced or Transplanted Tumors. Cell Rep. 2018 01 02; 22(1):27-35.
-
Tbx3 fosters pancreatic cancer growth by increased angiogenesis and activin/nodal-dependent induction of stemness. Stem Cell Res. 2016 09; 17(2):367-378.
-
A time frame permissive for Protein Kinase D2 activity to direct angiogenesis in mouse embryonic stem cells. Sci Rep. 2015 Jul 07; 5:11742.
-
Genetic variants in VEGF pathway genes in neoadjuvant breast cancer patients receiving bevacizumab: Results from the randomized phase III GeparQuinto study. Int J Cancer. 2015 Dec 15; 137(12):2981-8.
-
[Mechanisms of tumour cell dissemination and methods for detection of circulating tumour cells in transitional cell carcinoma]. Aktuelle Urol. 2011 Mar; 42(2):122-7.
-
Tumor cell dormancy: implications for the biology and treatment of breast cancer. APMIS. 2008 Jul-Aug; 116(7-8):742-53.